Evidence map›Paper›PMID 26864029›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.

Derrick R Samuelson, Nicholas M de la Rua, Tysheena P Charles, Sanbao Ruan, Christopher M Taylor, Eugene E Blanchard, Meng Luo, Alistair J Ramsay, Judd E Shellito, David A Welsh

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The respiratory tract microbial biogeography in alcohol use disorder.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Derrick R SamuelsonSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112;ORCID http://orcid.org/0000-0002-5356-1413
Nicholas M de la RuaSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112;
Tysheena P CharlesSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112;
Sanbao RuanSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112;
Christopher M TaylorDepartment of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112; and.ORCID http://orcid.org/0000-0002-7983-5275
Eugene E BlanchardDepartment of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112; and.
Meng LuoDepartment of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112; and.ORCID http://orcid.org/0000-0001-8626-6456
Alistair J RamsayDepartment of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112; and Louisiana Vaccine Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112.ORCID http://orcid.org/0000-0002-3506-4544
Judd E ShellitoSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112; Louisiana Vaccine Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112.ORCID http://orcid.org/0000-0001-7729-2708
David A WelshSection of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112; dwelsh@lsuhsc.edu.ORCID http://orcid.org/0000-0002-0008-6161

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Translational Research/Education ComponentP60AA009803 · NIAAA · LSU HEALTH SCIENCES CENTER · PI DAVID A WELSH · 2004 to 2026
$42.6M
Vaccine strategies against pneumocystis in non-human primatesP01HL076100 · NHLBI · LSU HEALTH SCIENCES CENTER · PI SHELLITO, JUDD E · 2004 to 2015
$17.7M
PILOT--IMPACT OF ALCOHOLISM ON AIDS ASOCIATED MUSCLE WASTINGP50AA009803 · NIAAA · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI NELSON, STEVE · 1994 to 2003
$7.2M
Novel Pneumocystis Surface Proteins as Vaccines to Prevent InfectionR21AI121731 · NIAID · LSU HEALTH SCIENCES CENTER · PI RUAN, SANBAO · 2016 to 2017
$403k
NHLBI NIH HHS P01 HL076100NHLBI NIH HHS P01-HL076100NIAAA NIH HHS P50 AA009803NIAAA NIH HHS P60 AA009803NIAAA NIH HHS P60-AA009803NIAID NIH HHS R21 AI121731NIGMS NIH HHS U54 GM104940NIGMS NIH HHS UG54-GM104940
6 · The paper itself

Abstract

Pneumocystis pneumonia is a major cause of morbidity and mortality in immunocompromised patients, particularly those infected with HIV. In this study, we evaluated the potential of oral immunization with live Pneumocystis to elicit protection against respiratory infection with Pneumocystis murina. C57BL/6 mice vaccinated with live P. murina using a prime-boost vaccination strategy were protected from a subsequent lung challenge with P. murina at 2, 7, 14, and 28 d postinfection even after CD4(+) T cell depletion. Specifically, vaccinated immunocompetent mice had significantly faster clearance than unvaccinated immunocompetent mice and unvaccinated CD4-depleted mice remained persistently infected with P. murina. Vaccination also increased numbers of CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD11b(+) macrophages in the lungs following respiratory infection. In addition, levels of lung, serum, and fecal P. murina-specific IgG and IgA were increased in vaccinated animals. Furthermore, administration of serum from vaccinated mice significantly reduced Pneumocystis lung burden in infected animals compared with control serum. We also found that the diversity of the intestinal microbial community was altered by oral immunization with P. murina. To our knowledge, our data demonstrate for the first time that an oral vaccination strategy prevents Pneumocystis infection.

Indexed as

Administration, OralAnimalsAntibodies, FungalFemaleFungal VaccinesHumansImmunizationImmunoglobulin AImmunoglobulin GLungLymphocyte ActivationMacrophagesMiceMice, Inbred C57BLPneumocystisPneumonia, PneumocystisAntibodies, FungalFungal VaccinesImmunoglobulin AImmunoglobulin G

Identifiers

PMID26864029
PMCPMC4779750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.